Devicemaker Medtronic has entered into a settlement with Dan Abrams Co. in a yearslong spine device fraud lawsuit, according to a Dec. 2 report from Bloomberg Law.

Medtronic has reported revenue gains across several of its ... while the technology is under review at the FDA. In medical ...

Medical devicemaker Medtronic has had a busy year filled with tech innovation, leadership appointments and restructuring efforts. Here are 19 updates from the company in 2024: 1. Medtronic received ...

Medtronic reported its second-quarter financial results for the fiscal year 2025, showing a 5.3% increase in total revenue, reaching $8.4 billion. The company also saw 5% growth in organic revenue, ...

Medtronic received Food and Drug Administration clearance ... is gaining strong acceptance in international markets. Simplera ...

Medtronic (MDT) ended the recent trading session at $87.53, demonstrating a +1.78% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 1. ...

2 Medtronic Nellcor™ SpO2 device vs. Masimo SET™* SpO2 device In 2022, a leading hypoxemia research laboratory team evaluated device performance and accuracy of the Medtronic Nellcor™ SpO2 ...

Remote monitoring for patients with implanted cardiac electrophysiology devices may finally be coming of age in the U.K. thanks to a review of these systems by the National Institute for Health and ...